Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof
US7485294B2 · kind B2 · utility
5Cited by
7References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2003 |
| Grant date | Feb 3, 2009 |
| Priority date | — |
| Expiry date | May 5, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Forms of colonic delivery suited to be used orally and designed for colonic delivery of active ingredients selected from the group comprising enzymes capable of inactivating macrolide antibiotics and related compounds, enzymes capable of inactivating quinolones, and β-lactamases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.